Company news

Ocugen, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Ocugen Inc. Announces $23 Million Registered Direct Offering of Common Stock Priced at a Premium to Market

February 6, 2021

Ocugen and Bharat Biotech Announce Execution of Definitive Agreement for the Commercialization of COVAXIN™ in the US Market

February 1, 2021

Ocugen Inc. Announces the Cancellation of Stockholder Meeting Previously Adjourned to 11: 00 a.m. Eastern Time on January 13, 2021

January 11, 2021

Ocugen Establishes Vaccine Scientific Advisory Board

December 22, 2020

Ocugen Inc. Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares

December 21, 2020

Ocugen Inc. Announces Plan to Postpone Annual Meeting of Stockholders

December 9, 2020

Ocugen Provides Business Update and Third Quarter 2020 Financial Results

November 5, 2020

Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200

October 5, 2020

Ocugen Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

September 7, 2020

Ocugen Provides Business Update and Second Quarter 2020 Financial Results

August 13, 2020

Ocugen Receives Fourth FDA Orphan Drug Designation for the Same Product, OCU400 (AAV-NR2E3) Gene Therapy, for the Treatment of Another Key Inherited Retinal Disease (IRD), PDE6B Gene Mutation-Associated Retinal Diseases

August 9, 2020

Ocugen to Host Conference Call on Friday, August 14 at 8: 30 a.m. ET to Discuss Second Quarter 2020 Financial Results and Provide Business Update

August 5, 2020

Ocugen Granted FDA Orphan Drug Designation for OCU400 (AAV-hNR2E3) Gene Therapy for the Treatment of RHO Mutation-Associated Retinal Degenerative Disease

July 26, 2020

Ocugen Appoints Dr. Mohamed Genead as Chair of Retina Scientific Advisory Board

June 2, 2020

Ocugen to Discontinue Phase 3 oGVHD Trial

May 31, 2020

Ocugen Provides Business Update and First Quarter 2020 Financial Results

May 7, 2020

Ocugen Announces Completion of Warrant Exchange

April 21, 2020

Ocugen Appoints Kirsten Castillo and Prabhavathi Fernandes to Board of Directors

April 6, 2020

Ocugen Provides Business Update and Full Year 2019 Financial Results

March 26, 2020

Ocugen Announces Completion of 50% of Enrollment of its Phase 3 Clinical Trial for ocular GVHD

December 8, 2019

Ocugen Provides Business Update and Third Quarter 2019 Financial Highlights

November 7, 2019

Ocugen Announces Warrant Restructuring

November 5, 2019

Ocugen Announces Appointments to Retina Disease and Ocular Graft-Versus-Host Disease Scientific Advisory Boards

November 3, 2019

Ocugen Appoints Jessica Crespo, CPA, as Controller

October 22, 2019

Ocugen Announces Share Repurchase Program

October 8, 2019

← Newer news releases

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 75 decks. Every deck is listed under its year.